• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Cannabis

Pot Stock Saturation Is Turning the Cannabis Bull Market Into a Bear

The wave of names going public is leaving investors confused and overwhelmed.
By DEBRA BORCHARDT
Nov 21, 2018 | 11:51 AM EST
Stocks quotes in this article: TLRY, ACRZF, MJARF, HTHHF

It seems like it wasn't so long ago that Tilray (TLRY) stock was hitting $300 in intraday trading. Now it's dropped to approximately $104.

Last week, the market welcomed three new cannabis stocks to the trading arena and investors were less than enthusiastic about the valuations. All three stocks opened below the level that the new shares were priced at and all three still haven't recovered to those original prices.

"I think the lackluster open for these stocks is largely attributed to an oversaturation of US cannabis companies listing on the CSE," said Matt Karnes, founder of GreenWave Advisors. "Consequently, it may become increasingly more difficult for similar enterprises to follow. I think the ongoing weakness is attributed to the revenues miss last week by some of the Canadian LPs compounded by the recent market selloff."

Karnes is right. As numerous cannabis companies all jump in the crush to go public, the investors are confused and overwhelmed. As a result, the prices have slumped and the field has become saturated.

Acreage Holdings began trading last Thursday on the Canadian Securities Exchange. The symbol is ACRG.U ( (ACRZF) on the pink sheets) with the "u" indicating that it is a Canadian stock but one that trades in U.S. currency. This caused some confusion on the first day as many new investors weren't sure of the significance of the ".U" and many just dropped the U and then couldn't figure out why their trades weren't going through.

There was a lot of market anticipation for this stock. CEO Kevin Murphy has assembled a star-studded board of directors including former Speaker of the House John Boehner, who is rumored to have been compensated in the seven figures for his participation. There is also former Canadian Prime Minister John Mulroney and former Governor of Massachusetts Bill Weld. It's also the cannabis company with the largest footprint and looks to be run by a solid group of executives.

Acreage priced its shares at $25 but the stock only opened at $19.75. The stock managed to go to $26.18 on Monday but quickly fell back down to $20.50. The company has made the decision to buy the shares a difficult one because it didn't disclose any financial numbers.

President George Allen said he wants investors to buy shares based on the extensive footprint of the company. Since Acreage did an RTO (reverse takeover) it wasn't required to disclose any financial numbers.

Another established cannabis company, MJardin began trading on the Canadian Securities Exchange using the symbol MJAR last Thursday as well. The shares, which also trade on the pink sheets under the symbol (MJARF) , were priced at C$12, but it opened at C$6.75. It managed to get as high as $8.70, but it, too, has slid back down C$7.88.

Unlike Acreage, MJardin readily provided financial numbers, estimating that it will bring in $162 million in revenue in 2019 according to a published investor presentation. The 2020 estimates are for $325 million in revenue. MJardin has real numbers on which it bases its projections, but this is getting lost by the claims of other less established companies.

Unwilling to be left out of the stock party on Thursday, Harvest Health & Recreation also began trading on the CSE following its recently announced RTO with the symbol HARV.CN ( (HTHHF) pink sheets). Its shares were priced at $6.65 or in Canadian currency C$8.67. It opened lower at C$5.50 and then closed down on the first day at C$7. It was lately trading at C$7.24, not nearly off as much as its peers.

The company has licenses to be in 11 states, but at this time is only operational in four states with four stores. Going public brought the company's capital raise up to $218 million.

The RTO was made possible through a series of actions, including an exchange of shares between existing shareholders of the acquired company, a share exchange between existing holders of common shares of Harvest FINCO, Inc., and an amalgamation among the Corporation, Harvest Finco Canada and 1185928 B.C. Ltd. The company said it plans more acquisitions.

One of the reasons the stocks look to be doing so poorly is that investors have trouble discerning the big companies from the small. They all claim to be the LARGEST cannabis company in the MOST states. Yet many of these new companies, with the exception of Acreage, only have plans or options to be in multiple states. They claim to be present in states in which they don't have an actual operation, only a license that was purchased.

Green Growth Brands, for instance, went public in November as well with the symbol GGB.CN following an RTO with Xanthic Biopharma. The company is led by a group of former executives from Victoria's Secret with little cannabis experience, but deep retail experience. They are convinced that the pioneers of cannabis haven't figured out how to be proper retailers. To date, the company only has one dispensary under its belt, but it has a slick presentation deck with beautiful pictures. It acquired The Source in Vegas which already was doing $17 million in sales before the retail experts took over.

If the companies were more upfront about the places where they have physical, live, functioning businesses versus planned businesses, then investors could make better-informed choices. As of now, this lack of transparency in the hopes of cashing in on the "green rush" of the cannabis stock rally only hurts the industry instead of helping it.

The cannabis bull market is quickly turning into a bear.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Borchardt had no positions in any securities mentioned.

TAGS: Investing | Cannabis

More from Cannabis

What's Up With the SPAC Silver Spike Acquisition?

Bruce Kamich
Jan 22, 2021 9:58 AM EST

WM Holdings, a cloud software provider for the cannabis industry, will soon be coming public by a reverse merger with SSPK.

My 'Aggressive', Under-the-Radar Stock Pick for 2021

Timothy Collins
Jan 21, 2021 12:15 PM EST

This cannabis-related model that sheds the commodity moniker and actually is a life sciences company.

Cannabis Leader Canopy Growth Can Climb Higher

Bruce Kamich
Jan 20, 2021 9:32 AM EST

Here's how to play CGC.

KushCo Sprinkles Some Gems on Its Earnings Call

Debra Borchardt
Jan 17, 2021 8:15 AM EST

The cannabis packaging company is looking at Arizona and New Jersey as new markets for growth.

I'm Coming Back Around to LiDAR Related Names

Timothy Collins
Jan 13, 2021 1:01 PM EST

Three stocks top my list for plays: Velodyne Lidar, Luminar Technologies, and Collective Growth Crop.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:01 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    I discuss price targets in my Saturday column.
  • 07:54 AM EST GARY BERMAN

    Friday Morning Fibocall for 1/22/2021

    SPX (Long-Term View) The 1/21/21 NEW high @ 3861...
  • 11:16 AM EST CHRIS VERSACE

    Worst Stocks to Buy for the Biden Presidency

    Biden's take on the minimum wage, likely moves on ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login